Pharma Companies are Clearly Out of Ideas for Drug Names


Well, I just saw one of those “ask your doctor about . . .” television spots for a new drug call Farxiga. That’s right FARXIGA. This new diabetes drug from AstraZeneca joins their other pharmaceutical offerings that now include FASLODEX, KOMBIGLYZE XR, LYNPARZA, ONGLYZA, and ZOMIG.

It really does seem like they’re now just grabbing a handful of Scrabble tiles and throwing them on a table and whatever randomly comes up becomes the new drug name. But their Scrabble set must come with lots of extra Xs, Ys and Zs.

XeljanzIt’s not just AstraZeneca. Pfizer is the maker of ELELYSO, FLYGYL, INYLTA, REBIF, SKELAXIN, TRUMENBA, and XELJANZ. Clearly, they long ago ran out of ideas and now they’re just messing with us.

How about these offerings from GlaxoSmithKline: LAMICTAL, TANZEUM, STAXYN, and RAXIBACUMAB.

Should you ask your doctor if RAXIBACUMAB is right for you? Let’s hope he says “no.” It’s a treatment for people who have inhaled anthrax.

Attention, Pharma companies! I hereby offer you my creative services for coming up with names for new drugs. I’ll even give you the first three at no charge.

YRRAL, YLRUC, and EOM*. (You’re welcome.)



*Larry, Curly and Moe